🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14,283 results for “B” Clear

  1. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Palliative Care

    phase 3 small molecule completed

    1 trial

  2. Placebo

    Takeda

    Non-erosive Gastroesophageal Reflux Disease

    phase 3 small molecule completed

    1 trial

  3. Placebo

    Pfizer

    Ulcerative Colitis

    phase 3 small molecule completed

    1 trial

  4. Placebo

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    1 trial

  5. Placebo

    Takeda

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    2 trials

  6. Placebo

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  7. Placebo

    Madrigal Pharmaceuticals EU Limited

    Non-Alcoholic Fatty Liver Disease

    phase 3 small molecule completed

    1 trial

  8. Placebo

    Takeda

    Hypertension

    phase 3 small molecule terminated

    1 trial

  9. Placebo

    Regeneron UK Limited

    Heterozygous Familial Hypercholesterolemia

    phase 3 small molecule completed

    1 trial

  10. Placebo

    LEXICON PHARMACEUTICALS, INC.

    Type 1 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  11. Placebo

    AstraZeneca

    Irritable Bowel Syndrome With Constipation (IBS-C)

    phase 3 small molecule completed

    1 trial

  12. Placebo

    Sanofi Pasteur

    Colorectal Neoplasms

    phase 3 small molecule completed

    1 trial

  13. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 small molecule completed

    1 trial

  14. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Adult Attention Deficit Hyperactivity Disorder

    phase 3 small molecule completed

    1 trial

  15. Placebo

    SUPERNUS PHARMACEUTICALS, INC.

    ADHD

    phase 3 small molecule completed

    5 trials

  16. Placebo

    Takeda

    Short Bowel Syndrome

    phase 3 small molecule completed

    1 trial

  17. Placebo

    Takeda

    Healthy Volunteers

    phase 3 small molecule completed

    2 trials

  18. Placebo

    Takeda

    Multiple Myeloma

    phase 3 small molecule completed

    1 trial

  19. Placebo

    Laboratoire HRA Pharma

    Leber congenital amaurosis (LCA)

    phase 3 small molecule active

    1 trial

  20. Placebo

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    phase 3 small molecule completed

    2 trials

  21. Placebo

    Takeda

    Diabetes

    phase 3 small molecule terminated

    1 trial

  22. Placebo

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis VI

    phase 3 small molecule completed

    1 trial

  23. Placebo

    NEUROCRINE BIOSCIENCES INC

    Dyskinesia

    phase 3 small molecule completed

    1 trial

  24. Placebo

    AbbVie

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources